`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
`
`
`
`
`
`
`
`
`
`
` Mailed: December 2, 2010
`
`Opposition No. 91184464
`Opposition No. 91184465
`
`Medimmune, Inc.
`
`
`v.
`
`
`SYGNIS Pharma AG
`
`
`
`
`
`
`
`Amy Matelski, Paralegal Specialist:
`
`Opposer’s consented motion to further suspend proceeding
`
`
`
`filed November 22, 2010 is noted.
`
`
`
`Because the parties are negotiating for possible
`
`settlement of this case, proceedings herein are suspended
`
`until January 22, 2011, subject to the right of either party
`
`to request resumption at any time. See Trademark Rule
`
`2.117(c).
`
`
`
`In the event that there is no word from either party
`
`concerning the progress of their negotiations, upon
`
`conclusion of the suspension period, proceedings shall
`
`resume on January 23, 2011 without further notice or order
`
`from the Board, upon the schedule set out in opposer’s
`
`motion.
`
`
`
`
`
`If the parties agree to another extension or
`
`suspension, they will be expected to report to the Board on
`
`the progress of discovery, or of any ongoing settlement
`
`negotiations. Such report must include: a recitation of
`
`discovery taken to date, a statement of issues that have
`
`been resolved and issues that remain to be resolved, and a
`
`firm timetable for resolution. Absent such a report, any
`
`future motion to extend or suspend may not be approved, even
`
`though agreed to by the parties.
`
`In each instance, a copy of the transcript of testimony
`
`together with copies of documentary exhibits, must be served
`
`on the adverse party within thirty days after completion of
`
`the taking of testimony. Trademark Rule 2.l25.
`
`Briefs shall be filed in accordance with Trademark Rule
`
`2.128(a) and (b). An oral hearing will be set only upon
`
`request filed as provided by Trademark Rule 2.l29.
`
`If, during the suspension period, either of the parties
`
`or their attorneys should have a change of address, the
`
`Board should be so informed.
`
`
`
`
`
`2